Enlitic, Inc. (ASX:ENL)
Australia · Delayed Price · Currency is AUD 0.0380
+0.0020 (5.56%)
Sep 30, 2026, 12:38 PM AEST
Enlitic Revenue
Enlitic had revenue of $1.69M USD in the half year ending June 30, 2026, with 727.39% growth. This brings the company's revenue in the last twelve months to $3.60M, up 30.17% year-over-year. In the year 2025, Enlitic had annual revenue of $3.80M with 251.87% growth.
Revenue (ttm)
$3.60M
Revenue Growth
+30.17%
P/S Ratio
0.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.62M AUD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.80M | 2.72M | 251.87% |
| Dec 31, 2024 | 1.08M | 582.94K | 117.55% |
| Dec 31, 2023 | 495.92K | -407.36K | -45.10% |
| Dec 31, 2022 | 903.28K | -390.69K | -30.19% |
| Dec 31, 2021 | 1.29M | 904.49K | 232.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.83B |
| Ramsay Health Care | 18.65B |
| Sigma Healthcare | 10.83B |
| Pro Medicus | 261.69M |
| Elixinol Wellness | 15.90M |
| Visionflex Group | 4.18M |
| Ocean Sciences | 3.44M |
| Osteopore | 2.93M |